Azure8 is a US-based, Women-Owned Company and was founded in 2018. Azure8 has a portfolio of innovative and patented technologies. Sonix-A8 is Class II Medical Device designed to prevent & control bacterial Infections before surgery during the surgery and post-surgery without the use of any chemical antiseptics. Our technology platform eliminates all Surgical Site Infections (SSI's) and reduces the bacterial burden (including MRSA) to prevent bacteremia and sepsis post-surgery. Sonix-A8 also can help eliminate catheter-related infections for dialysis patients. Sonix-A8 is a novel and smart medical device that destroys biofilms without developing resistant Superbugs.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Class II Medical Device;Patented and novel 'Infection Prevention and Control' technology platform
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):